- Approval Id
- 1eab3527ac1ed38b
- Drug Name
- YSP HYOSCINE INJECTION 20MG/ML
- Product Name
- YSP HYOSCINE INJECTION 20MG/ML
- Approval Number
- SIN16636P
- Approval Date
- 2022-11-07
- Registrant
- YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
- Licence Holder
- YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- INJECTION, SOLUTION
- Dosage
- <p><strong>Dosage and Administration(s):</strong><br>
YSP Hyoscine Injection 20mg/ml may be administered by Intramuscular or intravenous injection.</p>
<p>Adults<br>
One ampoule (20mg) should be given Im or IV, repeated after half an hour if necessary. Intravenous injection should be performed ‘slowly’ (in rare cases a marked drop in blood pressure and even shock may be produced). When used in endoscopy this dose may need to be repeated more frequently.<br>
Maximum daily dose of 100mg.<br>
Not recommended for children under 12 years old.</p>
<p><strong>Mode of Administration:</strong><br>
Intramuscular or intravenous</p>
- Route Of Administration
- INTRAVENOUS, INTRAMUSCULAR
- Indication Info
- <p><strong>Indication(s):</strong><br>
YSP Hyoscine Injection 20mg/ml is indicated in acute spasm, as in renal or biliary colic, in radiology for differential diagnosis of obstruction. It also indicated to reduce spasm and pain in pyelography, and in other diagnostic procedures where spasm may be a problem.</p>
- Contraindications
- <p><strong>Contraindications:</strong><br>
YSP Hyoscine Injection 20mg/ml are contraindicated in patients with:</p>
<ul class="dash">
<li>hypersensitivity to the active substance or to any of the excipients</li>
<li>narrow angle glaucoma</li>
<li>hypertrophy of the prostate with urinary retention</li>
<li>mechanical stenosis in the gastrointestinal tract</li>
<li>paralytical or obstructive ileus</li>
<li>megacolon</li>
<li>tachycardia</li>
<li>myasthenia gravis</li>
</ul>
<p>YSP Hyoscine Injection 20mg/ml should not be given by intramuscular injection to patients being treated with anticoagulant drugs since intramuscular haematoma may occur.</p>
- Pharma Manufacturer Name
- YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
- Company Detail Path
- /organization/yung-shin-pharmaceutical-singapore-pte-ltd
